Non-invasive Detection of Driveline Infections in Patients with a Left Ventricular Assist Device
DRIVE-ID
1 other identifier
observational
70
1 country
1
Brief Summary
The aim of this single center observational study is to determine the feasibility of using non-invasive imaging methods, including smartphone photography and infrared thermography, for detecting of DLIs in LVAD patients in terms of severity, extent and natural healing process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2024
CompletedFirst Submitted
Initial submission to the registry
September 5, 2024
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 10, 2025
September 1, 2024
2.9 years
September 5, 2024
March 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Extent and severity of driveline infections in LVAD patients using non-invasive imaging
Assess the extent, severity, and healing process of LVAD driveline infections in patients on LVAD support
26 weeks
Driveline exit healing process and risk of infection of the LVAD driveline
Assess the healing process of the driveline exit using non-invasive imaging (smartphone and thermographic)
26
Secondary Outcomes (2)
Sceptic complications
26 weeks
Machine learning model for predicting DLIs.
26 weeks
Study Arms (1)
Patients implanted with an LVAD
Eligibility Criteria
Patients implanted with an LVAD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erasmus Medical Centerlead
- Eindhoven University of Technologycollaborator
Study Sites (1)
Erasmus MC
Rotterdam, Netherlands
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
K. Caliskan, MD, PhD
Erasmus Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 26 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiologist
Study Record Dates
First Submitted
September 5, 2024
First Posted
March 10, 2025
Study Start
February 12, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 10, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data transfer is anticipated 1 October 2024 and 1 July 2025
- Access Criteria
- Coordinating researcher V. Drost will be able to access the IPD and supporting information via the investigation site.
Imaging data will be de-identified and then shared with Eindhoven University of Technology for further analyses and modeling.